Frankó, A. ; Berti, L. ; Hennenlotter, J.* ; Rausch, S.* ; Scharpf, M.O.* ; Hrabě de Angelis, M. ; Stenzl, A.* ; Peter, A. ; Birkenfeld, A.L. ; Lutz, S.Z. ; Häring, H.-U. ; Heni, M.
Increased expressions of matrix metalloproteinases (MMPs) in prostate cancer tissues of men with type 2 diabetes.
Biomedicines 8:507 (2020)
Type 2 diabetes (T2D) is associated with worse prognosis of prostate cancer (PCa). The molecular mechanisms behind this association are still not fully understood. The aim of this study was to identify key factors, which contribute to the more aggressive PCa phenotype in patients with concurrent T2D. Therefore, we investigated benign and PCa tissue of PCa patients with and without diabetes using real time qPCR. Compared to patients without diabetes, patients with T2D showed a decreased E‐cadherin/N‐cadherin (CDH1/CDH2) ratio in prostate tissue, indicating a switch of epithelial‐mesenchymal transition (EMT), which is a pivotal process in carcinogenesis. In addition, the gene expression levels of matrix metalloproteinases (MMPs) and CC chemokine ligands (CCLs) were higher in prostate samples of T2D patients. Next, prostate adenocarcinoma PC3 cells were treated with increasing glucose concentrations to replicate hyperglycemia in vitro. In these cells, high glucose induced expressions of MMPs and CCLs, which showed significant positive associations with the proliferation marker proliferating cell nuclear antigen (PCNA). These results indicate that in prostate tissue of men with T2D, hyperglycemia may induce EMT, increase MMP and CCL gene expressions, which in turn activate invasion and inflammatory processes accelerating the progression of PCa.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Cc Chemokine Ligand ; Diabetes ; Epithelial‐mesenchymal Transition ; Matrix Metalloproteinase ; Prostate Cancer; Epithelial-mesenchymal Transition; Metformin; Risk; Metaanalysis; Mortality; Chemokine; Mellitus; Therapy
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2020
Prepublished im Jahr
HGF-Berichtsjahr
2020
ISSN (print) / ISBN
2227-9059
e-ISSN
2227-9059
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 8,
Heft: 11,
Seiten: ,
Artikelnummer: 507
Supplement: ,
Reihe
Verlag
MDPI
Verlagsort
Basel, Switzerland
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
90000 - German Center for Diabetes Research
30201 - Metabolic Health
Forschungsfeld(er)
Helmholtz Diabetes Center
Genetics and Epidemiology
PSP-Element(e)
G-502400-001
G-501900-065
G-500600-001
Förderungen
Bundesministerium für Bildung und Forschung
Copyright
Erfassungsdatum
2020-12-01